Literature DB >> 22914173

Association of high-sensitivity C-reactive protein with cardiometabolic risk factors and micronutrient deficiencies in adults of Ouagadougou, Burkina Faso.

Augustin N Zeba1, Hélène F Delisle, Clémentine Rossier, Genevieve Renier.   

Abstract

Increasing evidence suggests that high-sensitivity C-reactive protein (hs-CRP) is associated with cardiometabolic risk factors (CMRF) while being also related to micronutrient deficiencies. As part of a project on the double burden of under- and overnutrition in sub-Saharan Africa, we assessed the relationship between hs-CRP and both CMRF and micronutrient deficiencies in a population-based cross-sectional study carried out in the Northern district of Ouagadougou, the capital city of Burkina Faso. We randomly selected 330 households stratified by income tertile. In each income stratum, 110 individuals aged 25-60 years and having lived in Ouagadougou for at least 6 months were randomly selected, and underwent anthropometric measurements and blood sample collection. The prevalence of high hs-CRP was 39.4 %, with no sex difference. Vitamin A-deficient subjects (12.7 %) exhibited significant risk of elevated hs-CRP (OR 2.5; P= 0.015). Serum ferritin was positively correlated with log hs-CRP (r 0.194; P= 0.002). The risk of elevated hs-CRP was significant in subjects with BMI ≥ 25 kg/m² (OR 6.9; 95 % CI 3.6, 13.3), abdominal obesity (OR 4.6; 95 % CI 2.2, 7.3) and high body fat (OR 10.2; 95 % CI 5.1, 20.3) (P< 0.001, respectively). Independent predictors of hs-CRP in linear regression models were waist circumference (β = 0.306; P= 0.018) and serum TAG (β = 0.158; P= 0.027). In this sub-Saharan population, hs-CRP was consistently associated with adiposity. Assuming that plasma hs-CRP reflects future risk of cardiovascular events, intervention which reduces CRP, or chronic and acute nutrition conditions associated with it, could be effective in preventing their occurrence particularly in sub-Saharan Africa.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914173     DOI: 10.1017/S0007114512003182

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  6 in total

1.  The association of the progression of knee osteoarthritis with high-sensitivity CRP in community-dwelling people-the Yakumo study.

Authors:  Fumiki Kondo; Yasuhiko Takegami; Shinya Ishizuka; Yukiharu Hasegawa; Shiro Imagama
Journal:  Clin Rheumatol       Date:  2021-01-11       Impact factor: 2.980

2.  Association between inflammatory obesity phenotypes, FTO-rs9939609, and cardiovascular risk factors in patients with type 2 diabetes.

Authors:  Meysam Alipour; Hosein Rostami; Karim Parastouei
Journal:  J Res Med Sci       Date:  2020-05-22       Impact factor: 1.852

3.  Zinc, iron and vitamins A, C and e are associated with obesity, inflammation, lipid profile and insulin resistance in Mexican school-aged children.

Authors:  Olga Patricia García; Dolores Ronquillo; María del Carmen Caamaño; Guadalupe Martínez; Mariela Camacho; Viridiana López; Jorge L Rosado
Journal:  Nutrients       Date:  2013-12-10       Impact factor: 5.717

4.  Metabolic syndrome and C-reactive protein in bank employees.

Authors:  Monica Cattafesta; Nazaré Souza Bissoli; Luciane Bresciani Salaroli
Journal:  Diabetes Metab Syndr Obes       Date:  2016-05-10       Impact factor: 3.168

5.  High-Sensitivity C-Reactive Protein is Related to Central Obesity and the Number of Metabolic Syndrome Components in Jamaican Young Adults.

Authors:  Nadia R Bennett; Trevor S Ferguson; Franklyn I Bennett; Marshall K Tulloch-Reid; Novie O M Younger-Coleman; Maria D Jackson; Maureen E Samms-Vaughan; Rainford J Wilks
Journal:  Front Cardiovasc Med       Date:  2014-12-16

6.  Changes in mineral status are associated with improvements in insulin sensitivity in obese patients following L-arginine supplementation.

Authors:  Joanna Suliburska; Paweł Bogdanski; Monika Szulinska; Danuta Pupek-Musialik; Anna Jablecka
Journal:  Eur J Nutr       Date:  2013-05-25       Impact factor: 5.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.